Introduction
Globally, norovirus (NoV) are a common cause of viral diarrhoea and vomiting in children <5 years [1] . Awareness of NoV has heightened with the improvement of diagnostics to detect the virus and the identification of NoV as an important cause of food-borne illness globally [2, 3] . A systematic review of NoV in sporadic gastroenteritis cases conducted in 2014 estimated that NoV was responsible for 18% (95% confidence interval (CI) 15%-20%) of gastroenteritis among children <5 years [1] . A previous review in 2008 estimated that NoV was responsible for 12% (95% CI 10%-15%) of severe diarrhoea in children <5 years and projected 218 000 deaths in children <5 years in developing countries annually [4] . While NoV infections are generally self-limiting, outcomes can be severe in individuals with comorbidities, extremes of age (<5 and >65 years) or following the emergence of new strains [5, 6] . A study conducted in the United States demonstrated that children <5 years have the highest rates of NoV associated health care visits and adults ≥65 years have the greatest risk of death due to NoV [7] .
Norovirus disease in children is generally mild, however, severe outcomes do occur with hospitalization rates between 7.2 and 16 hospitalizations/10 000 population <5 and an estimated 9.9-12% of diarrhoeal deaths annually [7, 8] .
Mans and colleagues recently conducted a review of NoV epidemiology in Africa [9] . While data on NoV prevalence in patients with diarrhoea in sub-Saharan Africa are available, most of these studies have duration of less than two years or less than 300 specimens available for evaluation. Despite these limitations, the review revealed overall NoV prevalence in individuals with diarrhoea of 13.5% (961/7141; 95% CI 12.7-14.3), with children <1 year mainly affected in African settings [9] .
Research on NoV in South Africa dates back to 1993 [10] and originally focused on seroprevalence rates in all age groups which ranged from >50% to >90% [11, 12] . An early virus detection study applied a combination of electron microscopy and recombinant enzyme immunoassays against Norwalk (NV)-like and Mexico (MX)-like NoVs and reverse transcription-polymerase chain reaction (RT-PCR) for the detection of caliciviruses in paediatric stool specimens collected between 1991 and 1995 [13] . Norwalk-like and MX-like NoVs were detected in 0.2% (3/1296) and 2.2% (29/1296) specimens, respectively [13] .
Between November 2009 and February 2012, the multisite birth cohort study investigating pathogen-specific burdens of community diarrhoea (MAL-ED) included a site in Venda, SA [14] .
Norovirus incidence at this site was 9.52 (95% CI 7.06-12.83) NoV GII detected per 100 child-months and 5.09 NoV GI detected per 100 child-months [14] . Severity of NoV diarrhoea was comparable to other enteric pathogens detected, except RV, and undernutrition was identified as a risk factor for NoV disease [14] . Norovirus infections peaked in children 6-11 months of age [14] .
In immunocompromised hosts, NoV infections are reported to be more severe with prolonged symptoms and viral shedding [6] . However, the majority of these studies have been conducted in transplant recipients with limited information in HIV-infected individuals [6] . Persistent diarrhoea, lasting 7 months, was described in an HIV-infected adult patient with poor compliance to antiretroviral therapy and a chronic NoV infection [15] . Noroviruses were detected more often in HIV-infected compared to HIV-uninfected children [16, 17] .
In April 2009, a prospective sentinel surveillance system was established to monitor diarrhoeal disease in hospitalized children <5 years of age in SA. We aimed to describe the epidemiology of NoV between 2009 and 2013.
Materials and Methods

Study participants and sites
Hospitalized children <5 years with acute diarrhoea were enrolled in the sentinel diarrhoea surveillance study. 
Study enrolment and data collection
Written informed consent was obtained from the parents of patients prior to enrolment. Systematic sampling was used to enrol patients on a daily basis from Monday to Friday between 8am and 5pm.
Patients who refused to participate in the study were noted but no additional information was collected. Surveillance officers collected demographic, socio-economic and risk factor data from the parents by interview and additional clinical data from medical records on standardised questionnaires. Data on HIV status of the mother and child was obtained during the interview or review of the medical records. If the status of the child was unknown and the parent gave consent, a dried blood spot was collected for anonymised HIV testing.
Laboratory screening
A stool specimen was collected for enteric pathogen detection. Nucleic acids were extracted from 10% stool suspensions using the QIAamp Viral RNA Mini Kit (Qiagen Inc., Valencia, CA) according to the manufacturer's instructions and eluted in 60µl RNase-free water. Briefly, 10µl extracted RNA was reverse transcribed with random primers using the Transcriptor First Strand cDNA Synthesis Kit (Roche, Mannheim, Germany) according to the manufacturers' instructions. Samples were screened for NoV GI and GII in monoplex reactions using 5µl cDNA, LightCycler 480 Probe Master Kit (Roche) and primers and probes from published methods [18] [19] [20] . Screening of other enteric viruses, bacteria and parasites has been described elsewhere [21, 22] .
A fully screened specimen was defined as a specimen where all viral, bacterial and parasite testing had been performed (n=1354).
Dried blood spots were screened using the AmpliPrep (Roche) for automated nucleic acid extraction and COBAS TaqMan (Roche) for automated real-time detection of HIV-1.
Data analysis
Norovirus detection rate was calculated using data from years with 12 months of surveillance (2010) (2011) (2012) (2013) . Demographic data, clinical characteristics and environmental features associated with NoV detection were compared in patients with or without NoV, genogroup GI or GII using Stata12 (StataCorp LP, College Station TX). In addition, the characteristics of HIV-infected and HIV-uninfected children were compared in NoV positive cases. Norovirus negative cases were defined as cases where neither NoV GI nor GII strains were detected. Mixed infections were defined as detection of NoV GI or GII strains with any of the following pathogens: RV, human adenovirus (any group), astrovirus, sapovirus (SaV), bocavirus, bacteria (Campylobacter spp., diffusely adherent Escherichia 
Norovirus epidemiology
Norovirus detection was higher in children 0-6 months and 7-12 months compared to children older than 24 months (0-6 months adjusted odds ratio (aOR)=2.2; 95% CI 1.4-3.6; p=0.001; 7-12 months aOR=2.2 95% CI 1.3-3.5; p=0.002; Table 1 ). This result was echoed in the individual analyses of GII and GI strains although the result was not statistically significant in multivariable analysis of GI (Supplementary Table 1and 2). The NoV detection rate by sentinel site was similar ranging from 10.0% in Mapulaneng Hospital (MPH) to 16.1% in Edendale Hospital (EDH) over the study period (Table 1) .
Norovirus GII were frequently detected from September to December each year ( Figure 1 ). The percentage positive NoV GII during this period was 20.5% (163/797) compared to the rest of the year (9.3%; 214/2306; p<0.001). The monthly detection rate of NoV GI strains in SA was less pronounced than NoV GII although the average detection in late summer (January to April) was 4.3% (43/1009) compared to 2.4% for the rest of the year (May -December; 51/2094; p=0.01; Figure 1 ). 
Clinical characteristics of NoV infections
Vomiting was more frequently identified in NoV positive compared to NoV negative children (OR=1.3; 95% CI 1.1-1.7; p=0.011; 
Environmental features associated with NoV detection
Informal housing compared to brick houses (aOR=0.7; 95% CI 0.5-1.0; p=0.021; Table 1 ). These results were also significant when noroviruses were stratified according to genogroup (Supplementary table 1 and 2).
The odds of detecting NoV GI strains increased 2.0 times when NoV GII strains were present (95% CI 1.2-3.3) and 2.0 times when SaV was present (95% CI 1.1-3.7; Supplementary Table 2) compared to single NoV GI cases. The association between NoV GI and SaV was maintained when adjusted for month of collection (aOR=1.9 (95% CI 1.0-3.5); p=0.041). Similarly, the NoV GI / NoV GII association also maintained statistical significance when adjusted for month of collection (aOR=1.9 (95% CI 1.1-
3.3); p= 0.017).
Norovirus infection in HIV-infected and HIV-uninfected children
The Table 2 ) than HIV-uninfected children on multivariable analysis. In addition, HIV-infected children with NoV had 2.4 times greater odds than HIV-uninfected children of experiencing diarrhoea duration of 3 days or more compared to 2 days or less (95% CI 1.2-4.9; p=0.018; Table 2 ).
Discussion
The An earlier study in SA in 2008 detected NoV in 14% of hospitalized children <2 years [23] . Previous studies in Africa have also identified NoV in an average of 13.5% of diarrhoea cases [9] . Similarly, a worldwide systematic review of studies conducted between 1990 and 2008 estimated that NoV was responsible for 12% of severe diarrhoea cases in children <5 years [3] . These results are comparable to the current study findings with NoV detection (GI and GII strains) at 15% in hospitalized South
African children.
Norovirus has often been described as "winter vomiting disease" due to the winter seasonality and occurrence of vomiting symptoms [6] . Globally, NoV infections seem to be more common during the winter months [24, 25] Norovirus GII strains identified in a 2008 study in Pretoria indicated that eight GII (GII.1, GII.4, GII.6, GII.7, GII.10, GII.13, GII.14, GII.16) strains were circulating [23] . While genotyping data from 2010 revealed that GII.2, GII.3, GII.4, GII.12 and GII.17 strains were circulating [28] , only limited typing was performed on the 2010 GII strains (39/216; 18%). Therefore, with the current data available, the In agreement with recent NoV data [6, 29] , vomiting was a significant symptom associated with NoV detection in South African children hospitalized for diarrhoea. However, children with NoV were not dehydrated and admitted for a median of two days. These results suggest that children with NoV detected are probably brought to the hospital for the treatment of numerous vomiting episodes rather than severe dehydration or diarrhoea. In NoV challenge studies, vomiting was more prevalent than diarrhoea and nearly half of the participants who experienced vomiting did not report diarrhoea symptoms [29] . Based on the surveillance case definition, NoV cases presenting as only vomiting or treated in the outpatients department will have been missed. Furthermore, a large proportion of children with NoV may not have required medical treatment resulting in an under estimation of the true prevalence of NoV diarrhoea in children <5 years in South Africa.
Norovirus GI strains have been detected at similar levels to GIIs in river water in SA [30] but were not seen at comparable levels in hospitalized patients (12% versus 3%). These results suggest that either NoV GI strains survive longer in the environment or patients shed NoV GI strains at higher titres [31] or NoV GI strains cause less severe or asymptomatic infections. Furthermore, these cases may be treated at home or at a clinic level which means that they would not be captured by the study surveillance system.
The exception to the perceived mild nature of GI infections may be in HIV-infected children. The current study indicated increased detection of single GI infections in HIV-infected children compared to HIV-uninfected children (9% versus 1%) in children admitted for the treatment of diarrhoea. In addition, the median NoV GI Ct values in HIV-infected children were also significantly lower compared to HIV-uninfected children (p=0.05). These results combined could be used as an indicator of NoV GI disease severity in HIV-infected children. Similar differences in disease severity in RV and
NoV GII infections in HIV-infected and HIV-uninfected patients have not been reported. However, this may be due to our inability to distinguish subtle differences in clinical severity between the two populations rather than the absence i.e. diarrhoea infections associated with RV and NoV GII strains are severe regardless of immune status.
A study by Groome and colleagues [32] estimated that 26% of children admitted with acute gastroenteritis to CHBAH, Johannesburg between March 1998 and October 2000 were HIV-infected, based on the prevalence rate in women attending antenatal clinics in the area. While the study did not detect more frequent RV infections in HIV-infected children, the absolute burden of disease in these children was twofold higher than in HIV-uninfected children [32] . In addition, HIV-infected children were more likely to be hospitalized for a longer period and had a higher case fatality rate [32] . A similar trend was noted in the current study where NoV strains were detected at similar levels in HIV-infected and HIV-uninfected children. However, NoVs were associated with a higher case fatality rate in HIV-infected children compared to HIV-uninfected children.
Population denominators were unavailable for the surveillance sites and; therefore, the incidence and increased risk of NoV associated with HIV infections could not be calculated. However, the mean HIV prevalence among children 0-4 years with NoV detected was 9.7% (43/443) between 2009 and 2013 while the HIV prevalence among children 0-4 years in the general population was 3.3% in 2008
[33], a threefold increase. These results suggest that HIV infection may be associated with hospitalization of NoV cases in children and further study may be warranted.
Analysis of the environmental features associated with NoV detection found that NoVs were less common in diarrhoeal patients living in informal housing (aOR=0.7; p=0.021) compared to brick housing or using external water sources (aOR=0.7; p=0.045) compared to indoor water. The role of continuous environmental exposure to NoV strains in these settings is unclear. Future study including control groups from the same community without diarrhoea would be required to interrogate these findings further.
The study has several limitations that should be considered when evaluating the findings. Missing data was dealt with by pairwise deletion and information selection bias may be present affecting the estimates and associations observed. The comparison groups used for the analysis were not strict control groups with the absence of diarrhoea and may have resulted in an underestimation of the clinical and environmental features associated with NoV infections. While patients who refused to participate in the study were noted, no additional information was gathered from these patients and, therefore, there may be non-participation biases unaccounted for in the analysis. The study enrolled children who were admitted to hospital overnight and was limited to moderate to severe diarrhoea. Therefore, any findings are restricted to this category of diarrhoeal infections and should be extrapolated to less severe outcomes with care. Not all the participants included in the study had specimens screened for all enteric pathogens. Limited clinical specimen volumes resulted in reduced screening for parasites. This may have resulted in an underestimation of mixed infections and affected the analysis of single pathogen infections.
Asymptomatic infections and prolonged shedding of enteric pathogens complicates epidemiological evaluations when trying to establish whether a pathogen is associated with an illness. Asymptomatic NoV infections have been described in paediatric patients at frequencies between 11.6-49.2% in a recent review [6] . An Australian study recorded NoV GII shedding in seven young children for 2-100 days [34] . In addition, NoV shedding in immunocompromised patients has been recorded for up to 898 days [35] . The current study did not have any data on asymptomatic NoV infections or duration of NoV shedding and the frequency of mixed pathogen NoV cases ranged from 77-66%.
However, efforts have been made to translate the faecal NoV viral load measurements or Ct values as a proxy measure into disease-attribution cut-offs [36] . An English study calculated an optimal Ct cut-off for children <5 of 30 [36] . As no South African Ct-disease-attribution analysis of the NoV realtime detection assay has been performed, the current study included all specimens positive for NoV 
Financial support
The sentinel diarrhoea surveillance programme was funded by GlaxoSmithKline (E-Track 200238).
The funders were not involved in study design, writing or publication of the paper. 
Declaration of interests
